European Commission does U-turn on human tissue regulation
This article was originally published in Clinica
Tissue-engineered products containing non-viable human tissues and cells may now be excluded from the long-awaited human tissue-engineered product Regulation being drafted by the European Commission's Directorate General Enterprise. Industry learnt of the surprise turnaround during a meeting with the Commission on June 23, Shayesteh Furst-Ladani, chair of the cell and tissues working group at industry association EuropaBio, told the 12th annual ABHI/IBC Global Conferences meeting on Medical Device Regulation, on June 24.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.